Literature DB >> 24589588

[Effects of metformin on human oral cancer KB cell proliferation and apoptosis in vitro].

Fang Wang1, Jincheng Xu, Fei Xia, Zhe Liu, Surong Zhao, Hao Liu, Zhiwen Jiang.   

Abstract

OBJECTIVE: To investigate the effects of metformin on the proliferation and apoptosis of human oral cancer cell line KB in vitro.
METHODS: Human oral cancer cell line KB was exposed to different doses of metformin (0, 1.25, 2.5, 5, 10, and 20 mmol/L), and the changes in cell viability were detected using MTT assay. Colony formation of the cells was observed following an 8-day metformin exposure. The changes in mitochondrial membrane potential were measured by JC-1 assay, and PI staining was used to observe the cell apoptosis. Western blotting was employed to detect the changes in the protein expressions of GRP78 and activated caspase-3.
RESULTS: Metformin exposure caused time- and dose-dependent suppression of KB cell proliferation, and exposure to 5 mmol/L metformin for 24, 48 and 72 h resulted in cell survival rates of 68.0%, 36.9%, and 14.5%, respectively. Metformin significantly inhibited KB cell colony formation. Exposure of the cells to increased concentrations of metformin gradually increased the apoptotic rate and decreased mitochondrial membrane potential. Metformin caused an initial up-regulation followed by a down-regulation of GRP78 expression in KB cells and increased the expression of activated caspase-3.
CONCLUSION: Metformin can inhibit the proliferation and induce apoptosis of KB cells, the mechanism of which may involve the activation of the mitochondrial apoptotic pathway and endoplasmic reticulum stress.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24589588

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  2 in total

Review 1.  Targeting the unfolded protein response in head and neck and oral cavity cancers.

Authors:  Daniel W Cole; Peter F Svider; Kerolos G Shenouda; Paul B Lee; Nicholas G Yoo; Thomas M McLeod; Sean A Mutchnick; George H Yoo; Randal J Kaufman; Michael U Callaghan; Andrew M Fribley
Journal:  Exp Cell Res       Date:  2019-05-07       Impact factor: 3.905

2.  Anti-tumor effects of metformin on head and neck carcinoma cell lines: A systematic review.

Authors:  Daniela Fortunato Rêgo; Silvia Taveira Elias; AngéLica Amorim Amato; Graziela De Luca Canto; Eliete Neves Silva Guerra
Journal:  Oncol Lett       Date:  2016-12-20       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.